- Phone
-
Address
No. B627, Zone B, Changjiang Software Park, 180 Changjiang South Road, Shanghai
Shanghai Shenzhixin Biotechnology Co., Ltd
No. B627, Zone B, Changjiang Software Park, 180 Changjiang South Road, Shanghai
Isolation and culture of endothelial progenitor cells from human peripheral blood:
Endothelial progenitor cells are precursor cells of vascular endothelial cells. Under physiological or pathological stimuli, they can be mobilized from bone marrow to peripheral blood to participate in the repair of damaged blood vessels. Research has shown that endothelial progenitor cells play an important role in cardiovascular and cerebrovascular diseases, peripheral vascular diseases, tumor angiogenesis, and wound healing, providing new ideas for the research and treatment of ischemic diseases. Endothelial progenitor cells have migratory characteristics and can further proliferate and differentiate into immature endothelial cells. They lack the characteristic phenotype of mature endothelial cells and cannot form luminal structures. Its main function is to participate in the angiogenesis of ischemic tissue after birth and the repair of vascular injury, making it a hot topic in the study of repair after ischemic disease injury.
Case Show:


Company Profile
Shanghai Shenzhixin Biotechnology Co., Ltd. is an innovative enterprise that provides systematic and high-quality research services for cardiovascular related diseases. It builds a basic medical and clinical translation service system and carries out preclinical CRO services based on pharmacological evaluation, providing various mature cardiovascular disease model animals. . Provide customized animal models, drug screening, pharmacological efficacy evaluation, safety evaluation, pathological analysis, and molecular biology testing services for research institutes, clinical departments, and pharmaceutical enterprises.